User profiles for M. McCallum

Matthew McCallum

- Verified email at uw.edu - Cited by 3827

Meaghan McCallum

- Verified email at brown.edu - Cited by 2444

Effects of perinatal mental disorders on the fetus and child

…, SH Goodman, E Rapa, A Rahman, M McCallum… - The Lancet, 2014 - thelancet.com
Perinatal mental disorders are associated with increased risk of psychological and
developmental disturbances in children. However, these disturbances are not inevitable. In this …

[HTML][HTML] Digital support interventions for the self-management of low back pain: a systematic review

…, LF Sandal, MJ Stochkendahl, M McCallum… - Journal of medical …, 2017 - jmir.org
Background Low back pain (LBP) is a common cause of disability and is ranked as the most
burdensome health condition globally. Self-management, including components on …

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver …

…, J Johnson, W Li, D Mansour, M McCallum… - The lancet …, 2022 - thelancet.com
Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the
general population. The evidence base for the investigation and management of NAFLD is …

SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern

M McCallum, J Bassi, A De Marco, A Chen, AC Walls… - Science, 2021 - science.org
A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429), which was originally
detected in California, carries spike glycoprotein mutations S13I in the signal peptide, W152C …

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

M McCallum, N Czudnochowski, LE Rosen, SK Zepeda… - Science, 2022 - science.org
… The results of the work conducted by Mccallum M et al. provide important information in
the development of neutralizing monoclonal antibodies against the omicron type SARS-CoV-2 …

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

…, FA Lempp, D Pinto, HV Dang, LE Rosen, M McCallum… - Science, 2020 - science.org
Efficient therapeutic options are needed to control the spread of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) that has caused more than 922,000 fatalities as of 13 …

[PDF][PDF] N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

M McCallum, A De Marco, FA Lempp, MA Tortorici… - Cell, 2021 - cell.com
The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding
domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little …

Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants

M McCallum, AC Walls, KR Sprouse, JE Bowen… - Science, 2021 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission leads to the
emergence of variants, including the B.1.617.2 (Delta) variant of concern that is causing a …

Non-colonic features of irritable bowel syndrome.

PJ Whorwell, M McCallum, FH Creed, CT Roberts - Gut, 1986 - gut.bmj.com
In 100 patients with irritable bowel syndrome a wide variety of non-gastrointestinal symptoms
were significantly more common than in a group of 100 age, sex, and social class matched …

[PDF][PDF] SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses

…, MJ Navarro, C Stewart, E Cameroni, M McCallum… - Cell, 2022 - cell.com
Although infections among vaccinated individuals lead to milder COVID-19 symptoms
relative to those in unvaccinated subjects, the specificity and durability of antibody responses …